Cargando…

High-throughput microarray for antimicrobial susceptibility testing

We describe the development of a novel, high-throughput, nano-scale microarray platform for antimicrobial susceptibility testing (AST). The platform allows to process 480 samples at 50 nL volume on a single chip, analyze by fluorescence read-out with an easy dunk-and-rinse step, and the ability to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Anand, Lee, Grace C., Torres, Nelson S., Hernandez, Kevin, Dallas, Steven D., Lopez-Ribot, Jose, Frei, Christopher R., Ramasubramanian, Anand K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686425/
https://www.ncbi.nlm.nih.gov/pubmed/29167758
http://dx.doi.org/10.1016/j.btre.2017.10.004
Descripción
Sumario:We describe the development of a novel, high-throughput, nano-scale microarray platform for antimicrobial susceptibility testing (AST). The platform allows to process 480 samples at 50 nL volume on a single chip, analyze by fluorescence read-out with an easy dunk-and-rinse step, and the ability to process multiple samples and chips simultaneously. We demonstrate the applicability of this chip for culturing community acquired methicillin resistant Staphylococcus aureus (CA-MRSA), and perform AST against clinical isolates of CA-MRSA. The chip platform holds promise for an impact in microbial biotechnology as an attractive high-throughput, lower sample volume and quicker alternative to conventional AST such as the traditional broth microdilution or the newer automated systems.